Clinical Trials Browser

Active not recruiting × Prostate Cancer Metastatic × Docetaxel × Clear all

NCT02913196 2025-05-23

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Phase 1 Active not recruiting

Prostate Cancer Metastatic